Safety-adverse focus
Melanotan 2 Side Effects: What the Research Shows
From the routine and short-lived to the serious and case-reported — the documented adverse effects, sorted by how often and how severely they show up.
The short version
Melanotan 2 side effects fall into two tiers. The common, usually-mild tier shows up in almost every account: nausea, facial flushing, an urge to stretch and yawn, tiredness in the first days, and — most consistently — moles and freckles getting darker. These are uncomfortable but generally pass.
The serious tier comes from published case reports, not large trials, but it is real: new and atypical moles, melanoma, muscle breakdown with kidney injury, kidney infarction, prolonged painful erections, and brain swelling. The thread connecting them is the peptide's potent, broad signaling and the fact that the products are unregulated. This page lays out both tiers with citations; the most serious events get their own deep-dive on the dangers page.
Common, usually short-lived side effects
The everyday side-effect profile is consistent across the controlled studies and the user reports. Nausea is the most common, typically arriving within an hour of a dose and worst in the early days; in the controlled erectile-dysfunction work it appeared as transient nausea, stretching, and yawning that needed no treatment [2], and nausea was documented as an aversive effect in animal studies [22]. Facial flushing and a hot feeling are commonly reported soon after dosing. A run-down, flu-like tiredness in the first days — nicknamed "melanotan flu" by users — is common and usually fades. Because the compound is injected, redness, swelling, itching, bruising, or small lumps at the injection site are commonly reported with repeated use. None of these are trivial, but they are the milder end of the spectrum.
Skin and pigment side effects
The pigment effects are where the cosmetic appeal and the medical concern collide. Beyond an overall tan, the literature documents darkening of existing moles and freckles [11], new (eruptive) moles appearing — sometimes within 24 hours of a single dose [10][8] — and dysplastic, or atypical, moles, which carry their own significance [11]. Dermoscopy studies show measurable changes in pigmented lesions during use [4]. Users also report selective darkening of lips, gums, scars, and genital skin, and uneven, blotchy, or unnaturally long-lasting color. The reason these matter medically rather than merely cosmetically is that changing pigmented lesions are exactly the signal clinicians use to screen for skin cancer — which is the subject of the next tier and the dangers page.
Serious, case-reported adverse events
The serious side effects are documented in the case-report literature. Melanoma and melanoma in situ have been reported in melanotan users [12][13][14]. A Melanotan 2 injection has been linked to systemic toxicity with rhabdomyolysis — severe muscle breakdown — alongside acute kidney injury requiring intensive care [5], and a separate case describes renal infarction associated with use [6]. Priapism, a prolonged and painful erection that is a urological emergency, appears in several reports, including after apparent overdose [16][17][18]. Posterior reversible encephalopathy syndrome — a form of brain swelling — has also been reported [19]. These are individual cases rather than incidence rates, but each is biologically consistent with the compound's known actions, and together they define the serious end of the melanotan 2 dangers.